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A randomised controlled trial comparing the effect of adjuvant intrathecal
2 mg midazolam to 20 micrograms fentanyl on postoperative pain for patients
undergoing lower limb orthopaedic surgery under spinal anaesthesia.
Codero Francis, Mung’ayi Vitalis, Sharif Thikra
Department of Anaesthesia, Aga Khan University, East Africa
Abstract

Background: Intrathecal adjuvants are added to local anaesthetics to improve the quality of neuraxial blockade and prolong the
duration of analgesia during spinal anaesthesia. Used intrathecally, fentanyl improves the quality of spinal blockade as compared
to plain bupivacaine and confers a short duration of post-operative analgesia. Intrathecal midazolam as an adjuvant has been
used and shown to improve the quality of spinal anaesthesia and prolong the duration of post-operative analgesia. No studies
have been done comparing intrathecal fentanyl with bupivacaine and intrathecal 2 mg midazolam with bupivacaine.
Objective: To compare the effect of intrathecal 2mg midazolam to intrathecal 20 micrograms fentanyl when added to 2.6 ml
of 0.5% hyperbaric bupivacaine, on post-operative pain, in patients undergoing lower limb orthopaedic surgery under spinal
anaesthesia.
Methods: A total of 40 patients undergoing lower limb orthopaedic surgery under spinal anaesthesia were randomized to two
groups.
Group 1: 2.6mls 0.5% hyperbaric bupivacaine with 0.4mls (20micrograms) fentanyl
Group 2: 2.6mls of 0.5% hyperbaric bupivacaine with 0.4mls (2mg) midazolam
Results: The duration of effective analgesia was longer in the midazolam group (384.05 minutes) as compared to the fentanyl
group (342.6 minutes). There was no significant difference (P 0.4047). The time to onset was significantly longer in midazolam
group 17.1 minutes as compared to the fentanyl group 13.2 minutes (P 0.023). The visual analogue score at rescue was significantly lower in the midazolam group (5.55) as compared to the fentanyl group 6.35 (P - 0.043).
Conclusion: On the basis of the results of this study, there was no significant difference in the duration of effective analgesia
between adjuvant intrathecal 2 mg midazolam as compared to intrathecal 20 micrograms fentanyl for patients undergoing lower
limb orthopaedic surgery.
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Introduction
Acute postoperative pain is one of the most common
postoperative problems, with an incidence up to 70%
in certain categories of surgical patients1. Apfelbaum et
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al2 conducted a national survey in the United States and
concluded that, acute post-operative pain continues to be
undermanaged with up to 60% of patients experiencing
moderate to severe pain at hospital discharge. A recent
study carried out at the Aga Khan University hospital investigated the incidence of post-operative pain after day
care surgery and concluded, that 56% of patients suffer
from moderate to severe pain after day care surgery3.
Acute post-operative pain is a complex physiological reaction to tissue injury which may result in unpleasant, unwanted sensory and emotional experiences4. It can result
in delayed healing, delayed mobilization and increased
African Health Sciences Vol 16 Issue 1, March 2016

risk of myocardial infarction or ischemia, risk of tachycardia and dysrhythmia. Other published reports indicate
that post-operative pain can lead to thromboembolic
events, peripheral vasoconstriction, and metabolic acidosis5,6. Controlling post-operative pain has the potential to
allow for earlier hospital discharge and may improve the
patient's ability to tolerate physical therapy.

complication is respiratory depression. The mechanism
is through the rostral spread immediately after injection
and with fentanyl and sufetanyl occurs within 20-30 minutes after injection. Evidence from small controlled studies and large observational studies13 show an incidence
of 0.07%-0.49% clinically significant, dose dependent,
and non-drug specific respiratory depression. Pruritus is
the most common complication with incidence of 30In the past few years various pharmacological and non- 100%14,15 and the management requires the administrapharmacological methods have been introduced to pro- tion of opioid antagonists naloxone and naltrexone16,17
vide post-operative pain-relief. Systemic analgesics and which in larger doses may reverse the analgesic effect17.
conventional pain treatment modalities are effective in There has been much recent attention towards the use
controlling post-operative pain for majority of patients. of benzodiazepine midazolam as an intrathecal drug in
However, many other patients such as those with com- treatment of acute and chronic pain18.
plex trauma, and extensive injuries, require more aggressive therapy to directly modulate pain transmission in the A study conducted by Kim et al19 however compared varcentral nervous system; and a high dose of systemic anal- ious doses of intrathecal midazolam 1mg and 2 mg plain
gesics may cause significant side effects such as alteration 0.5% hyperbaric bupivacaine, and found that time to first
in mental processes, respiratory depression, and other analgesia was significantly greater in the intrathecal group
cardiovascular instability.
compared to plain bupivacaine and even more so for the
2 mg group.
The use of intrathecal opioids in controlling post-oper- Based on the above stated author’s reviews it seems that 2
ative pain has developed from an understanding for the mg intrathecal midazolam has an obvious advantage over
role of the spinal cord for modulating and processing no- 1mg intrathecal midazolam as far as the density of the
ciceptive stimuli, and the discovery of opioid receptors in neural blockade and duration of postoperative analgesia.
the spinal cord7. Several agents have been administered Shadangi et al26 compared the effects of intrathecal bupiepidurally and intrathecally with and without local an- vacaine with or without 2 mg midazolam and concluded
aesthetic; such as opioids, benzodiazepines, neostigmine, that the addition of preservative-free midazolam to buclonidine, non-steroidal anti- inflammatory agents, vaso- pivacaine resulted in prolonged post-operative analgesia
constrictors. The objective of adding such agents is to without increasing motor block.
provide more adequate analgesia, reduce the use of oral The purpose of this study is to compare the effect of inanalgesics with unwanted side effects, and to prolong the trathecal bupivacaine with 2mg midazolam to intrathecal
duration of analgesia.
bupivacaine with 20 micrograms fentanyl on post-operative pain for patients undergoing lower limb orthopaedic
A vast number of researchers have demonstrated the effi- surgery under spinal anaesthesia.
cacy of intrathecal administration of opioids such as fentanyl and other agents such as midazolam in controlling Methods
post-operative pain8–11. Most of those studies have dem- The study was performed following approval from the
onstrated benefits and side effects using different doses Department of Anaesthesia and the Research and Reof fentanyl and midazolam in controlling post-operative- search Ethical Committees of the Aga Khan University.
pain8,10–12. Only one recent study by Talwar et al in 2008 Eligible patients were recruited after having signed an inhas been done to compare fentanyl 20 micrograms with formed consent, which clearly stated that it is a research
1mg midazolam in which they investigated the net effect study being conducted and that their information will be
kept confidential and may be published. The patients were
on post-operative pain and side effects20.
Intrathecal opioids are associated with numerous com- made to understand that they would receive health care
plications including respiratory depression, urinary re- as all other patients who came to theatre, and that they
tention, pruritus, nausea and vomiting. The most feared would not be denied care if they declined to participate
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in the study. For those who did not understand English
the above information on the pain scale and instructions
were explained in Swahili by the principal investigator
and further data collection by the research assistants were
done in Swahili.
An explanation on the study procedure was given to the
patient both verbally and using a written form. It was also
made clear there shall be no direct benefit to the patient
arising from participation in the study, but that the results
could be used to change local practice in the future. There
were no added expenses to the patient.
The patients voluntarily signed the consent form and
were recruited in the pre-anaesthesia review before coming to the operating theatres.
This was a prospective single blinded randomized controlled trial. The study was conducted at Aga Khan University hospital, Nairobi; a tertiary not for profit hospital
with a bed capacity of 250 beds and postgraduate medical
education programs in various disciplines. Since Nairobi
is a cosmopolitan city, the patients served by this hospital
cut across most racial groups present within the country.
Patients were recruited from the outpatient pre-anaesthesia clinics and as well inpatients from the wards.
The target population included all patients admitted for
lower limb orthopaedic surgery at the Aga Khan University Hospital, Nairobi. The sample population included
all ASA I, II and III patients scheduled for theatre for
lower limb orthopaedic surgery between October 2012
and January 2013.
Sample size calculation was based on the expected difference in mean duration of analgesia between intrathecal
midazolam and fentanyl effect. Sample size formula for
comparing two means was used to determine the required
sample size.
The reported mean duration of block for fentanyl is 296
(sd=73.64)20 and for midazolam 2mg is 399 (sd=60)21.
Using this information in the formula assuming 5% significance level and power of 90%, the required sample
size was 20 patients in each group (total of 40 patients).
A sample size of 40 patients was determined as sufficient
to demonstrate a 103 minute mean difference in the duration of effective analgesia between patients undergoing spinal anaesthesia with adjuvant 2mg midazolam and
those with adjuvant fentanyl at the Aga Khan University
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hospital. The study was powered at 90%. Type 1 error
was set at 0.05. The above formula was used since the aim
of the study was to determine the mean difference in the
duration of effective analgesia between the two intrathecal adjuvant medications.
Simple randomization was done using a computer program; the principal investigator generated a random sequence of numbers. Each of the random numbers was
sequentially assigned to either;
Group 1; 2.6mls 0.5% hyperbaric bupivacaine with 0.4mls
(20micrograms) fentanyl
Group 2; 2.6mls of 0.5% hyperbaric bupivacaine with
0.4mls (2mg) midazolam
At the pre-operative visit, an anaesthesiologist and /or
trained research nurse familiarized the patients with the
procedure of recording the post-operative pain scores
using a Visual analogue scale (VAS) -chart, which consists
of a 10cm line with 0 equalling “no pain” and 10 equalling “worst pain possible”.
A flow diagram of patient distribution is shown in figure
1.
This study was undertaken at the Aga Khan University
hospital, Nairobi operating theatres, ASA physical status
I-III patients scheduled for lower limb orthopaedic surgery and were randomized to either receive 2.6mls of
0.5% hyperbaric bupivacaine with 0.4mls (20mcg) fentanyl or 2.6mls of 0.5% hyperbaric bupivacaine with 0.4mls
(2mg) midazolam intrathecally at L3-S1 interspace. The
anaesthesiologist conducting the procedure (principal
investigator or research assistant) received together with
the data entry form the randomization group and administered the study drugs as per randomization group.
On arrival to the operating theatres, standard monitoring
was applied with automated non-invasive blood pressure
measurement, electrocardiography and pulse oximetry,
with the objective of obtaining the baseline cardiovascular parameters. Prior to performing the spinal anaesthesia
the patient would receive 500mls of Ringers lactate solution intravenously
After a local infiltration of 2ml 2% lidocaine solution,
a midline puncture with a 25 French gauge pencil point
needle was performed at L3-L4, L4-L5 interspace, with
the patient in the sitting or lateral decubitus position. After obtaining free flow of CSF, the study drugs previously
prepared by anaesthesiologist as per randomization group
were administered. Patients were then turned supine and
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the sensory block level to both light touch and temperature were checked at 2.5 minute intervals until there was
no change in 3 consecutive readings, the time of maximal
block was documented as the time of onset of the block.
After this, the anaesthesiologist assessed the modified
Bromage motor score (1 - able to move hip, knee and
ankle; 2 – unable to move hip, able to move knee and
ankle; 3 - unable to move hip and knee, able to move
ankle; 4 - unable to move hip, knee and ankle).Surgery
was allowed to commence as soon as the sensory block
height to light had been tested pre-incision and reached
the desired level. Subsequently the sensory block height,
the Bromage score, the vital signs (non-invasive blood
pressure, heart rate and oxygen saturation) and VAS were
determined and recorded every hour.
If pain or discomfort was felt, analgesia options of either
GA or supplementary analgesia with IV adjuncts such as
fentanyl 1-2mcg/Kg and IV paracetamol 1g was given.
Hypotension (defined as a reduction in MAP of more
than 20% from baseline determined just before the administration of regional anaesthesia) was treated with
ephedrine boluses of 6 mg. Bradycardia (defined as heart
rate less than 60bpm) was treated with atropine. The presence of intraoperative nausea, vomiting, pruritus, and
shivering was also noted and treated appropriately; rescue antiemetic drugs using a combination of IV ondansetron 4mg or granisetron 1mg were administered at the
discretion of the anaesthesiologist. Other complications
that patients developed were noted (inadequate blocks,
conversion to general anaesthesia, bradycardia, pruritus,
hypotension, respiratory discomfort, ephedrine use, colloids use, and crystalloid use). All the complications that
occurred were noted by the anaesthesiologist. At the end
of surgery, the patient received IV paracetamol 1g and
IM diclofenac 75mg.

height and vital signs (non-invasive blood pressure, heart
rate and arterial oxygen saturation). The time of request
first analgesia was taken as the first time the patient requested for analgesia or the VAS >/= 4.
Intraoperative data was collected by the principal investigator or trained research assistant using the data collection form.
Upon collection data was entered into the statistical software (SPSS version 15) on the same day in a coded form
and saved, awaiting analysis. All data entered was verified
by the principal investigator.
Data analysis was undertaken using the SPSS version 15
with the input of a statistician who had been involved
since the beginning of the study.
Descriptive statistics were used to compare patients’ characteristics in terms of age, sex, height, weight. Student’s
T test was used to compare if the 2 sample sizes were statistically different. The unpaired student’s t test was used
to compare the differences between duration of effective
analgesia and VAS at administration of rescue analgesia
The Chi test was used to compare the proportions of various complications between the two groups. Survival time
analysis (Kaplan Meir) was used to analyze the duration
of effective analgesia. Log rank test was used to compare
duration of effective analgesia.
A P value of < 0.05 was considered statically significant.

Results
Data collection was carried out over four months, October 2012 to January 2013. A total of 40 participants were
recruited from the outpatient clinic and surgical wards
and randomised for the study. All the participants recruited were followed up and included in the data analysis,
twenty in each arm.
Age, weight, height, ASA status were similar in both
The principal investigator together with the research as- groups. There was a significant difference in the number
sistants followed up the patients in the wards with hourly of males and females in either group (Table 1). There was
monitoring of the VAS, Bromage score, sensory block no significant difference in age, weight, height and ASA
status of the patients.

African Health Sciences Vol 16 Issue 1, March 2016

285

Table 1: Patient’s baseline characteristics
Midazolam

Fentanyl

‘P’

Age

44.6 (18.1)

52.6(17.6)

0.164

Height

163.9(15.9)

158.3(19.6)

0.324

Weight

75.8(11)

76.1(12.7)

0.947

ASA status

2.1(0.9)

2(0.9)

0.713

Sex( Male)

7

15

0.002

Sex (Female)

13

5

0.004

Note: Mean age, height, weight and ASA are presented as Mean +/_SD; t - test used for analysis

The majority of the procedures conducted were knee arthroscopy contributing to 32.5% of procedures conducted and the least was above knee amputation that contributed 2.5% of the total surgical procedures done. Table 2

shows the distribution of the procedures in each group.
The duration of effective analgesia in the midazolam
group 384.05minutes as compared to the fentanyl group
342.6 minutes; this was not significant (‘P’ -0.4047).

Table 2: Types of surgical procedures
Type of surgery

Midazolam group

Fentanyl group

Totals

Knee arthroscopy

8(40%)

5(25%)

13(32.5%)

Knee replacement

4(20%)

3(15%)

7(17.5%)

Hip replacement

0

3(15%)

3(7.5%)

ORIF femur

3(15%)

3(15%)

6(15%)

ORIF Tibia

1(5%)

1(5%)

2(5%)

ORIF ankle

3(15%)

5(25%)

8(20%)

1(5%)

0

5(2.5%)

20

20

40(100%)

Above
amputation
Total
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The time to onset was significantly longer in midazolam rescue was significantly lower in the midazolam group
group 17.1 minutes as compared to the fentanyl group 5.55 as compared to the fentanyl group 6.35 (‘P - 0.043’)
13.2 minutes (‘P - 0.023’). The visual analogue score at (Table 3).
Table 3: Primary outcome
Variable

Midazolam
Mean (sd)
(CI)

Fentanyl
Mean (sd)
(CI)

Mean difference ‘P’
(CI)

Time
to 17.1(6.5)
maximum block (14.08-20.12)
(minutes)

13.2(3.8)
(13.8-14.9)

3.95(0.6-7.3)

0.023

VAS at rescue

6.35(1.31)
(5.74-6.96)

0.8(0.02-1.57)

0.043

342.6(152.04)
(271-413)

41.45(0-141)

0.4047

Duration
effective
analgesia

5.55(1.099)
(5.04-6.06)
of 384.05(158.99)
(309-458)

Time to maximum block, VAS at rescue and duration of effective analgesia are presented as Mean
+/_SD and confidence intervals; t - test used for analysis

Intraoperatively there was a higher incidence of pruritus difference in the intraoperative incidences of nausea/
in the fentanyl group 57.9% as compared to none in the vomiting and sedation in the midazolam group as commidazolam group (‘p <0.001’). There was no significant pared to fentanyl group (table 4).
Table 4: incidence of intraoperative complications
Complications

Midazolam

Fentanyl

‘P’

Nausea / Vomiting

2(10%)

4(20%)

0.661

Hypotension

2(10%)

2(10%)

1.0

Pruritus

0

11(57.9%)

<0.001

Sedation

4(20%)

1(5%)

0.342

Respiratory depression

0

0
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Post operatively there was also no significant difference in

the incidence of side effects (Table 5).

Table 5: Incidence of post-operative complications
Complications

Midazolam

Fentanyl

‘P’

Urinary retention

1(5%)

3(15%)

0.605

Headache

5(25%)

5(25%)

1.0

Dizziness

4(20%)

4(20%)

1.0

Nausea / Vomiting

1(5%)

4(20%)

0.106

Respiratory depression

0

1(5%)

Figure 1: Flow diagram of patient’s
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Discussion
In this single blind randomized control study of 40 patients undergoing lower limb orthopaedic surgery under
spinal anaesthesia, there was no statistically significant
difference between the duration of effective analgesia
of adjuvant 2mg intrathecal midazolam as compared to
20mcg intrathecal fentanyl.
The rationale for the use of intrathecal midazolam focuses on the awareness that it is an agonist at the benzodiazepine binding site, a subunit of the pentamericgamma-aminobutyric acid (GABA A) receptor. Agonist
occupancy of the benzodiazepine binding site enhances
the activity of GABA at the GABA A receptor. This receptor is a chloride ionophore that, when activated, typically stabilises the transmembrane potential at, or near,
the resting potential. In neurons, this typically serves to
decrease excitability. Intrathecal benzodiazepine-induced
analgesia is spinally mediated. Binding sites are GABA receptors, abundantly present in the dorsal root nerve cells,
with the maximum concentration found within lamina II
of the dorsal nerve cells, a region that plays a prominent
role in processing nociceptive and thermoceptive stimulation21. The present cumulative experience with intrathecal midazolam across species broadly confirms the safety
thereof, the analgesic activity of the molecule and its benzodiazepine pharmacology, and the lack of irreversible
effects22.
In the present study it was observed, that there is no statistically significant difference in the duration of effective
analgesia, this finding is different from that of a previous study comparing the two drugs20. This relationship
may be explained by another study comparing19 different
doses of intrathecal midazolam that found that 2mg dose
of adjuvant midazolam had a longer duration of effective analgesia as compared to the 1mg dose. The confidence intervals obtained for the primary outcome were
very wide, since the study was powered for this outcome,
the reason could have been due to equivalence but the
study was not powered to determine this.
The ‘P’ obtained for the time to maximum block and VAS
score showed there may be a difference but this was not
statistically significant since there was an overlap of the
confidence intervals in duration and pain score obtained
between the two groups. In addition, the study was not
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powered to measure this difference and assess its significance.
Safari el al while studying the effect of adjuvant 1 mg
midazolam compared with 25 mcg fentanyl on the duration of spinal anaesthesia with 0.5% bupivacaine in opium abusers concluded midazolam is more effective than
fentanyl in such cases. Our study further confirms their
findings30.
The incidence of nausea and vomiting noted in this study
was determined to be 5% both intra-operatively and
post-operatively and this was lower than that of intrathecal fentanyl; these findings are similar to one done23 to
compare fentanyl, midazolam and placebo and found the
highest reduction in incidence of nausea was in the midazolam group. Our findings were comparable to those Ho
et al27 who in their meta-analysis of the use of intrathecal
midazolam to improve postoperative analgesia concluded
that it appeared to improve perioperative analgesia and
reduce nausea and vomiting in caesarean delivery.
The incidence of respiratory depression in the present
study was 5% of patients in the fentanyl group as compared to that of previous studies that found an incidence
of up to 3.4%13. This may be explained by the fewer number of patients who were recruited in our study and the
5% incidence is attributable to one patient who developed respiratory depression both intra-operatively and
post-operatively. The mechanism of intrathecal opioid induced respiratory depression is due to the rostral spread.
Various studies have found different incidences of sedation following intrathecal midazolam. In the study conducted by Talwar and colleagues20, the incidence of sedation was higher in the intrathecal fentanyl group than in
the intrathecal midazolam group. Dureja et al while assessing the efficacy of intrathecal midazolam with or without
methylprednisolone for management of post-herpetic
neuralgia involving lumbosacral dermatomes found a
mild degree of sedation in the midazolam group28. In the
present study, the incidence of sedation was higher in the
midazolam group than in the fentanyl group. This difference may have occurred due the higher intrathecal dose
of midazolam (2mg) that was used in the present study.
Niv and colleagues conducted neurotoxicologic studies
in animals by studying histologic and vascular lesions in
animal spinal cord samples, indicating the neurotoxic effects of intrathecal midazolam24. Therefore, they advised
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against the use of intrathecal midazolam in humans. Subsequent studies in humans9,25,29, found no adverse neurological symptoms in those who had received intrathecal
midazolam. In agreement with these studies, the present
study observed no significant adverse neurological effects
in any patient during the study period. Further current
reports suggest that midazolam in a dose of 1-2mg at a
concentration not exceeding 1mg/ml is not accompanied
by an increase in adverse events22.
Limitations.
One of the limitations of this study was that despite randomization there was heterogeneity as concerns the nature of the procedures, these procedures varied from arthroscopy to total hip replacement. This therefore meant
the difference in the extent of tissue damage and thereby
the nociceptive input was large and may have had an effect on the duration of effective analgesia.
Another limitation is the lack of standardization as concerns the use of local anaesthetic infiltration at the surgical site. This may have resulted the longer duration of effective analgesia for certain procedures due to the routine
use of local anaesthetic infiltration at the end of surgery
by some surgeons.
Conclusion
On the basis of the results of this study, there was no
difference in the duration of effective analgesia between
adjuvant intrathecal 2mg midazolam as compared to intrathecal 20micrograms fentanyl for patients undergoing
lower limb orthopaedic surgery.
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